Dazoxiben: a pharmacological tool or clinical candidate?
Open Access
- 1 February 1983
- journal article
- Published by Wiley in British Journal of Clinical Pharmacology
- Vol. 15 (S1) , 13S-16S
- https://doi.org/10.1111/j.1365-2125.1983.tb02101.x
Abstract
No abstract availableThis publication has 16 references indexed in Scilit:
- SELECTIVE INHIBITION OF THROMBOXANE SYNTHETASE BY DAZOXIBEN INCREASES PROSTACYCLIN PRODUCTION BY LEUCOCYTES IN ANGINA PATIENTS AND HEALTHY VOLUNTEERSThe Lancet, 1982
- The release of thromboxane during atrial pacing and the haemodynamic and metabolic effects of its inhibition by dazoxibenThe American Journal of Cardiology, 1982
- Elevation of thromboxane B2 levels in patients with classic and variant angina Pectoris.Circulation, 1981
- Do prostacyclin and thromboxane play a role in endotoxic shock?British Journal of Surgery, 1981
- THROMBOXANE SYNTHASE INHIBITION IN PATIENTS WITH ATHEROSCLEROTIC HEART DISEASEThe Lancet, 1981
- The effect of intravenous prostacyclin on resting pains and healing of ischaemic ulcers in peripheral artery diseaseProstaglandins and Medicine, 1981
- Release of Prostaglandins and Thromboxane into the Coronary Circulation in Patients with Ischemic Heart DiseaseNew England Journal of Medicine, 1981
- ADMINISTRATION TO MAN OF UK-37,248-01, A SELECTIVE INHIBITOR OF THROMBOXANE SYNTHETASEThe Lancet, 1981
- Treatment of vasospastic disease with prostaglandin E1.BMJ, 1980
- Thromboxane release during pacing-induced angina pectoris: possible vasoconstrictor influence on the coronary vasculature.Circulation, 1980